Histopathology Research Technician

at  University College London

ABOUT US

The UCL Cancer Institute is the hub for cancer research at University College London, one of the World’s leading universities. The Institute draws together over 400 talented scientists who are working together to translate research discoveries into developing kinder, more effective therapies for cancer patients. In particular, it fosters links between basic cancer researchers across Biomedicine and with the clinical activities of our four partner hospital trusts, known as UCL Partners (University College London Hospital NHS Foundation Trust, Great Ormond Street Hospital for Children NHS Trust, the Royal Free Hampstead NHS Trust, and Moorfields Eye Hospital NHS Foundation Trust), as well as the London School of Pharmacy and Cancer Research UK. The Institute has greater clinical links than any comparable centre in the UK, creating a unique opportunity for significant impact on the delivery of clinical service to cancer patients. The Cancer Institute includes the Cancer Research UK and UCL Cancer Trials Centre which is one of the largest cancer trials centres in the UK conducting multi-centre national and international phase III trials, feasibility studies and early phase I and II studies. Also embedded within the UCL Cancer Institute, the CRUK-UCL Centre provides essential infrastructure to support cancer research within UCL and is a major catalyst in the success of UCL in integrating translational and clinical cancer research with excellent basic science. Furthermore, the Institute offers educational programmes that reflect the depth and breadth of research expertise that include BSc Cancer Biomedicine, iBSc Oncology, MSc Cancer and PhD studies. Further Information about the UCL Cancer Institute can be found on our website https://www.ucl.ac.uk/cancer/

ABOUT YOU

The successful candidate must have sufficient breadth or depth of specialist knowledge in the discipline and of research methods and techniques in subject area and IHC/Immunofluorescence experience. Ability to contribute to method improvement where required and experience of working in a research environment are essential. Experience with digital pathology and image analyses, BSc and Masters in a biological or biomedical subject or equivalent experience are desirable but not essential.
Applications should include a CV and a Cover Letter: In the Cover Letter please evidence the essential and desirable criteria in the PersonSpecification part of the Job Description.
By including a Cover Letter, you can leave blank the
‘Why you have applied for this role’ field in the application form, which is limited in the number of characters it will allow

The main objective of the post is the development of cutting edge fluorescent multiplex immunostaining techniques using the PhenoImager HT platform (AKOYA, Biosciences) in usage at the Paul O’Gorman UCL Cancer Institute. The technology will be applied to address a range of biological questions using human and/or mouse FFPE tissues. Work will focus on: a) implement work on identification and characterization of novel diagnostic and/or prognostic biomarkers in cancers and to animal models and more important b) apply high number multi-marker spatial analyses of tissue microenvironment in haematological malignancies and solid tumours. This enables the progression of fundamental translational research methodologies that bridges the gap between academia, industry and the clinic, promoting collaboration across the fields.
This is a part time post 18.25 hours per week for 2 years.